Our Technology

NanOptima’s hydrogel drug depots are made from completely natural biocompatible and bioresorbable components, and are an innovative application of cutting-edge biomaterials research.
The unique technology allows the depot properties to be tuned bespoke to the properties of the biopharmaceutical of choice, and to modulate release rate.

Key Features of NanOptima’s Hydrogel delivery system:

  • Sustained release of biologics, beyond 4 months.
  • High loading of biologics.
  • Adaptable to a range of therapeutics including standard of care drugs: bevacizumab/aflibercept.
  • Injectable via standard 30G needle, no specialist training required.
  • Optically transparent.
  • Simple, biocompatible formulation.
  • Demonstrated excellent tolerability following in vivo intravitreal injection.
Partnering Opportunities

Key Features of NanOptima’s Hydrogel delivery system:

  • Provides sustained treatment beyond 4 months following a single administration
  • Longer-lasting treatments significantly reduce the number of annual injections required by patients whilst also significantly reducing the number of appointments clinicians are required to schedule.
  • This translates to more consistent treatment and greater compliance.
Partnering Opportunities

Together, we can drive transformative progress in ophthalmic care.

If you are interested in exploring partnership opportunities or learning more about our technology, we invite you to connect with us via the contact form below.